Showing results (4311-4320 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 20, 2019
Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic CancerIngrid Garajová, Rita Balsano, Chiara Tommasi, et al.Current Pharmaceutical Design|November 5, 2019
Integrating Autism Spectrum Disorder Pathophysiology: Mitochondria, Vitamin A, CD38, Oxytocin, Serotonin and Melatonergic Alterations in the Placenta and GutMichael Maes, George Anderson, Susana R Betancort Medina, et al.Current Pharmaceutical Design|November 5, 2019
Autism Spectrum Disorders: Role of Pre- and Post-Natal GammaDelta (γδ) T Cells and Immune RegulationGeorge Anderson, Susana R Betancort MedinaCurrent Pharmaceutical Design|November 6, 2019
Update on Autoimmune Diseases PathogenesisMelek KechidaCurrent Pharmaceutical Design|October 28, 2017
Antiepileptic Drugs for Preventing Seizures in Patients with Chronic Subdural HematomaPedro Moura Branco, Bernardo Oliveira Ratilal, Joao Costa, et al.Current Pharmaceutical Design|January 24, 2018
Inflammatory Arthritis and Heart DiseaseSantos Castaneda, Carlos Gonzalez-Juanatey, Miguel A Gonzalez-GayCurrent Pharmaceutical Design|January 30, 2018
Placental Exosomes During Gestation: Liquid Biopsies Carrying Signals for the Regulation of Human ParturitionCarlos Salomon, Zarin Nuzhat, Christopher L Dixon, et al.Current Pharmaceutical Design|August 24, 2017
The Food and Drug Addiction Epidemic: Targeting Dopamine HomeostasisKenneth Blum, Panayotis K Thanos, Gene-Jack Wang, et al.Current Pharmaceutical Design|August 30, 2017
Genetic Aspects of Glial Cells Regarding Neurodegenerative DiseasesJulio Cesar Martinez Lozano, Rosa Margarita Gomez, Andres Gabriel Zarate Sanabria, et al.Current Pharmaceutical Design|January 9, 2018
Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery DiseaseDongsheng Yu, Chuanfeng Tang, Peiyu Liu, et al.Pageof 1,008